The role of cerebrospinal fluid metabolites in mediating the impact of lipids on Late-Onset Alzheimer’s Disease: a two-step mendelian randomization analysis
Jie Jie, Yonglu Gong, Hongbo Hu, Su Liu · 2024
Read The role of cerebrospinal fluid metabolites in mediating the impact of lipids on Late-Onset Alzheimer’s Disease: a two-step mendelian randomization analysis by Jie Jie, Yonglu Gong, Hongbo Hu, Su Liu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11603644.txt.
Description
Blood lipids, spinal fluid chemistry, and late-onset Alzheimer's disease are linked, but the causal arrows are unclear. Jie Jie and three co-authors use Mendelian randomization, a genetics-based method that mimics a natural experiment, in two steps. First they test lipids against the disease both ways; then they ask whether spinal fluid metabolites carry part of any lipid effect.
Genetically predicted cholesterol slightly lowered disease risk, while one phosphatidylcholine raised it. A single metabolite, N-acetylneuraminate, mediated about a fifth of one lipid pathway's effect. Robustness checks found no sign of the usual biases. The authors present spinal fluid chemistry as a window into how lipids feed the disease, and the metabolite as a candidate marker. The study appears in 2024.
Catalog record
| CREATOR | Jie Jie, Yonglu Gong, Hongbo Hu, Su Liu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |